Opioid-induced cardioprotection against myocardial infarction and arrhythmias: Mitochondrial versus sarcolemmal ATP-sensitive potassium channels

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 2, 2000, Pages 451-457

  Fryer, Ryan M ^a   Hsu, Anna K ^a   Nagase, Hiroshi ^b   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; CLAMIKALANT; DELTA OPIATE RECEPTOR AGONIST; OPIATE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOLEMMA;

ADENOSINE TRIPHOSPHATE; ANALGESICS, OPIOID; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; BENZAMIDES; BLOOD PRESSURE; DECANOIC ACIDS; DRUG INTERACTIONS; HEART RATE; HYDROXY ACIDS; MALE; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; QUINOLINES; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; SARCOLEMMA; VENTRICULAR FIBRILLATION;

EID: 0033913629     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. + channels in rabbit heart. Am J Physiol 277:H128-H135.
2. Bian J, Zhang W, Xia Q and Wong T (1998) Phospholipase C inhibitors attenuate arrhythmias induced by κ-receptor stimulation in the isolated rat heart. J Mol Cell Cardiol 30:2103-2110.
3. Billman G, Englert H and Scholkens B (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: Effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther 286:1465-1473.
4. Curtis M and Walker M (1988) Quantification of arrhythmias using scoring systems: An examination of seven scores in an in vivo model of regional myocaridal ischemia. Cardiovasc Res 22:656-665.
5. ATP channel in the preservation of mitochondrial function. Am J Physiol 278:H305-H312.
6. ATP channels. Circ Res 84:846-851.
7. Fryer R, Schultz J, Hsu A and Gross G (1998) Pretreatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in the rat heart. Am J Physiol 275:H2009-H2015.
8. Fryer R, Schultz J, Hsu A and Gross G (1999b) Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol 246:H1229-H1235.
9. Gogelein H, Hartung J, Englert H and Scholkens B (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: Effects on cardiomyocytes, coronary flow and pancreatic B-cells. J Pharmacol Exp Ther 286:1453-1464.
10. Gross G and Auchampach J (1992) Blockade of the ATP-sensitive potassium channels prevents myocardial preconditioning. Circ Res 70:223-233.
11. + channels and myocardial preconditioning. Circ Res 84:973-979.
12. Gutstein H, Rubie E, Mansour A, Akil H and Woodgett J (1997) Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology 87:1118-1126.
13. + channel in the mitochondrial inner membrane. Nature (Lond) 352:244-247.
14. ATP channel. J Cardiovasc Pharmacol 32:337-342.
15. Kita H, Miura T, Tsuchida A, Hasegawa T and Shimamoto K (1998) Suppression of reperfusion arrhythmias by preconditioning is inhibited by an ATP-sensitive potassium channel blocker, 5-hydroxydecanoate, but not by protein kinase C blockers in the rat. J Cardiovasc Pharmacol 32:791-797.
16. Klein H, Puschmann S, Schaper J and Schaper W (1981) The mechanism of the tetrazolium reaction in identifying myocardial infarction. Virchows Arch 393:287-297.
17. Kukreja R and Qian Y (1997) Tyrosine kinase pathway is involved in ischemic preconditioning in rat heart. J Mol Cell Cardiol 29:A230.
18. Lee A, Chen Y, Kan M, Peng F, Chai C and Kuo J (1992) Consequences of opiate agonists and antagonists in myocardial ischemia suggst a role of endogenous opioid peptides in ischaemic heart disease. Cardiovasc Res 26:392-395.
19. ATP channels. Circ Res 84:1386-1400.
20. 2 opioid receptors in arrhythmogenesis. Clin Exp Pharmacol Physiol 29:716-123.
21. Liu Y, Ytrehus K and Downey J (1994) Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26:661-668.
22. Maslov L, Krylatov A and Lishmanov Y (1996) On the involvement of endogenous μ- and δ-opiate receptor agonists in antiarrhythmic effect of adaptation. Bull Exp Biol Med 121:20-21.
23. Maulik N, Watanabe M, Zu Y, Huang C, Cordis G, Schley J and Das D (1996) Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396:233-237.
24. Maulik N, Yoshida T, Zu Y, Sato M, Banerjee A and Das D (1998) Ischemic preconditioning triggers tyrosine kinase signaling: A potential role for MAPKAP kinase 2. Am J Physiol 44:H1857-H1864.
25. Miki T, Cohen M and Downey J (1998) Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 186:3-12.
26. Murphy D and Murphy M (1999) Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias: A peripheral mechanism. J Cardiovasc Pharmacol 33: 122-125.
27. Murry C, Jennings R and Reimer K (1986) Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136.
28. Pepe S, Xiao R, Hohl C, Altschuld R and Lakatta E (1997) 'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart. Circulation 95: 2122-2129.
29. Ping P, Zhang J, Cao X, Qiu Y, Tang X, Clerk A, Sugden P and Bolli R (1998) Activation of the p38 MAPK and the p46/p54 JNKs after brief episodes of ischemia/reperfusion in the heart of conscious rabbits. J Mol Cell Cardiol 30:A263.
30. Ping P, Zhang J, Qiu Y, Tang X, Manchikalapudi S, Cao X and Bolli R (1997) Ischemic preconditioning induces selective translocation of protein kinase C isoforms ∈ and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81:404-414.
31. Podzuweit T, Els D and McCarthy J (1981) Cyclic AMP mediated arrhythmias induced in the ischaemic pig heart. Basic Res Cardiol 78:443-448.
32. + channels by protein kinase C. Circ Res 83:110-114.
33. ATP channels in ischemic cardioprotection. Circulation 101:2418-2423.
34. Schultz J, Hsu A and Gross G (1996) Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78:1100-1104.
35. 1-but not μ- or κ-opioid receptors. Circulation 97:1282-1289.
36. ATP channels. Am J Physiol 274:H909-H914.
37. ATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J Mol Cell Cardiol 29:1055-1060.
38. Schultz J, Rose E, Yao Z and Gross G (1995) Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 268:H2157-H2161.
39. Schultz J, Yao Z, Cavero I and Gross G (1997b) Glibenclamide-induced blockage of ischemic preconditioning is time dependent in intact rat heart. Am J Physiol 272:H2607-H2615.
40. Speechly-Dick M, Mocanu M and Yellon D (1994) Protein kinase C: Its role in ischemic preconditioning in the rat. Circ Res 75:586-590.
41. Utz J, Eckert R and Trautwein W (1995) Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the δ-opioid agonist U50488H does not involve binding to opiate receptors. J Pharmacol Exp Ther 274:627-633.
42. Weinbrenner C, Liu G, Cohen M and Downey J (1997) Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 29:2383-2391.
43. ATP-channel opening and arrhythmogenesis. J Cardiovasc Pharmacol 24:S35-S40.
44. Wong T, Lee A and Tai K (1990) Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart - An attempt to identify cardiac opioid receptor subtype(s) involved in arrhythmogenesis. J Mol Cell Cardiol 22:1167-1175.
45. Wu J, Chen T and Lee A (1993) Opioids in myocardial ischaemia: Potentiating effects of dynorphin on ischaemic arrhythmia, bradycardia and cardiogenic shock following coronary artery occlusion in the rat. Eur Heart J 14:1273-1277.
46. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration and infarct size in dogs. Circulation 89:1768-1775.
47. Ytrehus K, Liu Y and Downey J (1994) Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266:H1145-H1152.
48. Yu X, Wang H, Pei J and Wong T (1999) Anti-arrhythmic effect of κ-opioid receptor stimulation in the perfused rat heart: Involvement of a cAMP-dependent pathway. J Mol Cell Cardiol 31:1809-1819.